SCHEMBL18504024

SCHEMBL18504024

c1ccc(-c2cc(-c3ccccc3)cc(-c3cccc(-c4cccc(-c5cc6ccccc6c(-c6cc(-c7ccncc7)ccn6)n5)c4)c3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.41
KDM4E B2RXH2 4/20 0.40
MAPT P10636 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
CYP19A1 P11511 1/20 0.40
PRKCH P24723 1/20 0.40
PRKCE Q02156 1/20 0.40
NOTUM Q6P988 1/20 0.40
MKNK1 Q9BUB5 1/20 0.39
DHODH Q02127 1/20 0.39
CDC7 O00311 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
MAPK13 O15264 1/20 0.38
GCGR P47871 1/20 0.38
MAPK12 P53778 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18503966 0.99 PIK3CA (0.42) PIK3CAKDM4EMAPTALDH1A1HPGD
SCHEMBL18504026 0.96 CYP19A1 (0.40) PIK3CAKDM4EMAPTCYP19A1IDO1
SCHEMBL18503982 0.95 TDO2 (0.40) PIK3CAKDM4EMAPTCYP19A1IDO1
SCHEMBL18504087 0.91 PIK3CA (0.41) PIK3CAKDM4EMAPTALDH1A1HPGD
SCHEMBL18504021 0.89 MKNK1 (0.46) PIK3CAKDM4EMAPTALDH1A1HPGD
SCHEMBL18504082 0.88 PIK3CA (0.37) PIK3CAKDM4EMAPTALDH1A1HPGD
SCHEMBL18504023 0.88 MKNK1 (0.48) PIK3CAKDM4EMAPTALDH1A1HPGD
SCHEMBL18503979 0.88 MKNK1 (0.47) PIK3CAKDM4EMAPTALDH1A1HPGD
SCHEMBL18503964 0.86 MKNK1 (0.49) PIK3CAKDM4EMAPTALDH1A1HPGD
SCHEMBL18504029 0.84 ALDH1A1 (0.46) PIK3CAKDM4EMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device SAMSUNG SDI CO., LTD. (KR) 2019-10-15 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device OXER1, OCIAD1, OCIAD2 PIK3CA 966/4885KDM4E 4289/4885MAPT 1518/4885
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE OXER1, OCIAD1, OCIAD2 PIK3CA 966/4885KDM4E 4289/4885MAPT 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.